Nationwide estimates of SARS‐CoV‐2 infection fatality rates and numbers needed to vaccinate for COVID‐19 vaccines in 2024 in Austria

Documenti analoghi

• Re: ‘Effectiveness of a fourth SARS‐CoV‐2 vaccine dose in previously infected individuals’
  di: Hinpetch Daungsupawong, et al.
  Pubblicazione: (2024)
• Lung damage in SARS ‐ CoV ‐2 patients: An autopsy study in the era of vaccination
  di: Rossana Bussani, et al.
  Pubblicazione: (2024)
• Correction to ‘Lung damage in SARS ‐ CoV ‐2 patients: An autopsy study in the era of vaccination’
  Pubblicazione: (2025)
• Evidence base for yearly respiratory virus vaccines: Current status and proposed improved strategies
  di: Mariana Barosa, et al.
  Pubblicazione: (2024)
• Lung damage in SARS‐CoV‐2 patients: Correspondence
  di: Hinpetch Daungsupawong, et al.
  Pubblicazione: (2024)